论文信息 - Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17‐DMAG, KOS‐1022) by the pediatric preclinical testing program - 字舞流文

Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17‐DMAG, KOS‐1022) by the pediatric preclinical testing program

S. Keir | J. Maris | P. Houghton | C. Morton | R. Lock | Malcolm A. Smith | D. Phelps | Jianrong Wu | C. Reynolds | E. Kolb | H. Carol